维普期刊资源整合服务平台（V6.5）

139篇 您的检索式：作者名="Wilkinson GR"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Identification of a new genetic defect responsible for the polymorphism of (S) -me- phenytoin metabolism in Japanese 显示文摘	De Morals SM Wilkinson GR Blaisdell J	1994	Mol Pharmacol1994，46，4：	1
2	A physiological approach to hepatic drug clearance显示文摘	Wilkinson GR Shand DG	1975	Clin Pharmacol Ther1975，18，4：	1
3	In vitro and in vivod drug interactions involving human CYP3A 显示文摘	Thummel KE Wilkinson GR	1998	Ann Rev Pharmacel Toxical1998，38，：	1
4	Disruption of c-Fos leads to increased expression of NAD(P) H: quinine oxidoreductasel and glutathione S-transferase 显示文摘	Wilkinson J Radjendirane V Pfeiffer GR	1998	Biochem Biophys Res Commun1998，253，3：	1
5	Clearance approaches in pharmacology 显示文摘	Wilkinson GR	1987	Pharmacol Rev1987，39，：	1
6	Drug metabolism and variability among patients in drug response显示文摘	Wilkinson GR	2005	N Engl J Med2005，352，21：	1
7	The oral yeast flora of 10-year-old schoolchildren显示文摘	Martin MY and Wilkinson GR	1983	Sabouraudia1983，21，：	1
8	The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans显示文摘	Wilkinson GR Blaisdell J Nakamura K Meyer UA Goldstein JA	1994	J Biol Chem1994，269，15：	1
9	Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients 显示文摘	Takahashi H Wilkinson GR Caraco Y	2003	Clin Pharmacol Ther2003，73，3：	1
10	Genetic and dietary predictors of CYP2E1 activity:a phenotyping study in Hawaii Japanese using chlorzoxazone显示文摘	Le Marchand Wilkinson GR Wilkens LR	1999	Biomark Prev1999，8，：	1
11	Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra-and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African- Americans显示文摘	Takahashi H Wilkinson GR Nutescu EA	2006	Pharmacogenet Genomics2006，16，2：	1
12	Identification of a new genetic defect responsible for the polymorphism of (S) -mephenytoin metabolism in Japanese 显示文摘	De Morals SM Wilkinson GR Blaisdell J	1994	Molecular Pharmacology1994，46，4：	1
13	Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance显示文摘	Rane A Wilkinson GR Shand DG	1977	J Pharmacol Exp Ther1977，200，2：	1
14	Population differences in S-warfarin metabolism between CYP2C9 genotype-matched Caucasian and Japanese patients 显示文摘	Takahashi H Wilkinson GR Cameo Y	2003	Clin Pharmacol Ther2003，73，3：	1
15	Debate: idiopathic short stature should be treated with growth hormone显示文摘	Ambler GR Fairchild J Wilkinson DJ	2013	J Paediatr''Child Health2013，49，3：	1
16	The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans显示文摘	De Morais SM Wilkinson GR Blaisdell J	1994	J Biol Chem1994，269，15：	1
17	Iden- tification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese 显示文摘	de MORAIS SM WILKINSON GR BLAISDELL J	1994	Mol Pharma- col1994，46，4：	1
18	Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese显示文摘	De Morais SM Wilkinson GR B1aisdell J	1994	Mol Pharmacol1994，46，4：	1
19	The major genetic defect responsible for the polymorphi of S-mephenytoin metaboli in humans显示文摘	De Morais SM Wilkinson GR Blaisdell J	1994	J Biol Chem1994，269，15：	1
20	Identification of a new genetic defect responsible for the polymorphism of (S)- mephenytoin metabolism in Japanese显示文摘	De Morais SM Wilkinson GR Blaisdell J	1994	Mol Pharmacol1994，46，4：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示